Skip to main content
Year archive

Brainsway Ltd. — 2024 filings

All 51 regulatory filings released by Brainsway Ltd. (BWAY) in 2024, sourced directly from the official regulator.

51 Filings
2024 Period
2024 filings (51)
Filing Released Lang
Reports Positive Independent Pilot Data on Accelerated Deep TMS Treatment of Alcohol Use Disorder
Regulatory Filings
2024-12-12 English
Reports Positive Independent Pilot Data on Accelerated Deep TMS Treatment of Alcohol Use Disorder
Report Publication Announcement
2024-12-12 English
BrainsWay Reports Promising Feasibility Data Showing Pain Reduction with Deep TMS Therapy
Regulatory Filings
2024-11-20 English
BrainsWay Reports Promising Feasibility Data Showing Pain Reduction with Deep TMS Therapy
Report Publication Announcement
2024-11-20 English
Third Quarter 2024 Financial Results and Operational Highlights
Interim / Quarterly Report Q3 2024
2024-11-12 English
Third Quarter 2024 Financial Results and Operational Highlights
Report Publication Announcement
2024-11-12 English
BrainsWay EGM Results and Valor PIPE Closing
Regulatory Filings
2024-11-05 English
BrainsWay EGM Results and Valor PIPE Closing
AGM Information
2024-11-05 English
BrainsWay Further Penetrates East Asia with Placement of 15 Additional Deep TMS™ Systems in Taiwan and South Korea
Regulatory Filings
2024-10-09 English
BrainsWay Further Penetrates East Asia with Placement of 15 Additional Deep TMS™ Systems in Taiwan and South Korea
Regulatory Filings
2024-10-09 English
convening of meeting extraordinary meeting on the day Tuesday on the date : 05/11/2024 time: 15:00
Proxy Solicitation & Information Statement
2024-10-01 English
convening of meeting extraordinary meeting on the day Tuesday on the date : 05/11/2024 time: 15:00
Proxy Solicitation & Information Statement
2024-10-01 English
convening of meeting extraordinary meeting on the day Tuesday on the date : 05/11/2024 time: 15:00
Board/Management Information
2024-10-01 English
convening of meeting extraordinary meeting on the day Tuesday on the date : 05/11/2024 time: 15:00
Proxy Solicitation & Information Statement
2024-10-01 English
BrainsWay Announces US$20 Million Private Placement with Valor Equity Partners
Regulatory Filings
2024-09-30 English
BrainsWay Announces US$20 Million Private Placement with Valor Equity Partners
Share Issue/Capital Change
2024-09-30 English
BrainsWay Announces Significant Expansion on U.S. East Coast
Regulatory Filings
2024-09-16 English
BrainsWay Announces Significant Expansion on U.S. East Coast
Report Publication Announcement
2024-09-16 English
Israel Ministry of Defense Clears BrainsWay Deep TMS™ for PTSD Reimbursement at Israeli Hospitals
Regulatory Filings
2024-09-10 English
Israel Ministry of Defense Clears BrainsWay Deep TMS™ for PTSD Reimbursement at Israeli Hospitals
Report Publication Announcement
2024-09-10 English
BrainsWay Appoints Richard A. Bermudes, M.D. as Chief Medical Officer
Regulatory Filings
2024-08-29 English
BrainsWay Appoints Richard A. Bermudes, M.D. as Chief Medical Officer
Board/Management Information
2024-08-29 English
Second Quarter 2024 Financial Results and Operational Highlights
Interim / Quarterly Report Q2 2024
2024-08-06 English
Second Quarter 2024 Financial Results and Operational Highlights
Earnings Release Q2 2024
2024-08-06 English
Form F-3 (Shelf) Registration Subject to completion, dated July 22, 2024
Capital/Financing Update
2024-07-22 English
Form F-3 (Shelf) Registration Subject to completion, dated July 22, 2024
Capital/Financing Update
2024-07-22 English
Results of Annual Shareholder Meeting held on June 17, 2024
AGM Information
2024-06-17 English
Results of Annual Shareholder Meeting held on June 17, 2024
AGM Information
2024-06-17 English
BrainsWay Expands Global Imprint with Exclusive Multi-Year Distribution Agreement in Canada
Regulatory Filings
2024-06-17 English
BrainsWay Expands Global Imprint with Exclusive Multi-Year Distribution Agreement in Canada
Regulatory Filings
2024-06-17 English
Launches Prospective, Randomized, Controlled, Multicenter Trial Evaluating Accelerated Deep TMS™ for Depression
Regulatory Filings
2024-06-10 English
Launches Prospective, Randomized, Controlled, Multicenter Trial Evaluating Accelerated Deep TMS™ for Depression
Report Publication Announcement
2024-06-10 English
BrainsWay Receives Expanded FDA Labeling to Treat Late Life Depression
Regulatory Filings
2024-06-03 English
BrainsWay Receives Expanded FDA Labeling to Treat Late Life Depression
Report Publication Announcement
2024-06-03 English
Immediate Report of Meeting to be held on June 17, 2024, proxy
Proxy Solicitation & Information Statement
2024-05-09 English
Immediate Report of Meeting to be held on June 17, 2024, proxy
Proxy Solicitation & Information Statement
2024-05-09 English
Immediate Report of Meeting to be held on June 17, 2024, proxy
AGM Information
2024-05-09 English
First Quarter 2024 Financial Results and Operational Highlights
Interim / Quarterly Report Q1 2024
2024-05-08 English
First Quarter 2024 Financial Results and Operational Highlights
Earnings Release Q1 2024
2024-05-08 English
BrainsWay Expands Deep TMS™ Access in Israel Following Significant Increase in Reimbursement Rates
Regulatory Filings
2024-04-17 English
BrainsWay Expands Deep TMS™ Access in Israel Following Significant Increase in Reimbursement Rates
Report Publication Announcement
2024-04-17 English
Announces Published Review Results Highlighting Potential of Deep TMS™ to Treat Parkinson's Disease
Regulatory Filings
2024-04-04 English
Announces Published Review Results Highlighting Potential of Deep TMS™ to Treat Parkinson's Disease
Report Publication Announcement
2024-04-04 English
FORM 20F For the fiscal year ended December 31, 2023
Annual Report FY 2023
2024-03-28 English
FORM 20F For the fiscal year ended December 31, 2023
Report Publication Announcement
2024-03-28 English
BrainsWay Broadens Partnership with Katie’s Way Plus Through Order of an Additional 18 Deep TMS™ Systems
Regulatory Filings
2024-03-18 English
BrainsWay Broadens Partnership with Katie’s Way Plus Through Order of an Additional 18 Deep TMS™ Systems
Regulatory Filings
2024-03-18 English
BrainsWay Reports Fourth Quarter and Full-Year 2023 Financial Results and Operational Highlight
Earnings Release Q4 2023
2024-03-06 English
BrainsWay Reports Fourth Quarter and Full-Year 2023 Financial Results and Operational Highlight
Report Publication Announcement
2024-03-06 English
BrainsWay Initiates Clinical Evaluation of Rotational Field “Deep TMS 360°™” Technology
Regulatory Filings
2024-01-10 English
BrainsWay Initiates Clinical Evaluation of Rotational Field “Deep TMS 360°™” Technology
Report Publication Announcement
2024-01-10 English